Fabry disease: kidney transplantation as an enzyme replacement technic
Philippart, M.
Birth Defects Original Article Series 9(2): 81-87
1973
ISSN/ISBN: 0547-6844 PMID: 4215478 Document Number: 69688
Document emailed within 1 workday
Related Documents
Schiffmann, R. 2006: Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy Acta Neurologica Belgica 106(2): 61-65Gómez Belda, A.B.; Rovira Daudí, E.; Julve Pardo, R.; Belda Mira, A. 1999: Bronchiolitis obliterans organizing pneumonia in a kidney transplantation patient with Fabry's disease Revista Clinica Espanola 199(3): 187-188
Riccio, E.; Pisani, A. 2014: The switch of enzyme therapy in Fabry disease Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 31(4)
Basić-Jukić, N.; Kes, P.; Hudolin, T.; Mesar, I.; Corić, M.; Kastelan, Z. 2011: Anderson-Fabry disease and renal transplantation Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65(4): 377-380
Hong, C.; Sutherland, D.E.; Matas, A.J.; Simmons, R.L.; Najarian, J.S. 1978: Enzyme replacement therapy in acatalasemic mice by bone marrow transplantation Surgical Forum 29: 333-335
Sumethkul, V.; Jirasiritham, S.; Chiewsilp, P.; Domrongkitchaiporn, S.; Sujirachato, K.; Mongkolsuk, T.; Sriphojanart, S.; Kanjanapanjapol, S.; Chakkaphak, S.; Leela-Udomlipi, S.; Leenanupunth, C.; Tirapanich, W.; Chaimuangraj, S.; Kochakarn, W.; Tapaneya-Olarn, W.; Tardtong, P.; Leungwattanakij, S.; Angkoolpakdeekul, T.; Lertchalorarn, K.; Tansupasiri, P.; Gojaseni, P. 2000: The organization of Kidney Transplantation Services at Ramathibodi Hospital: fourteen years experience on waiting list, kidney donors and kidney transplantation Journal of the Medical Association of Thailand 83 Suppl. 1: S35-S41
Kes, P.; Slavicek, J. 2013: Hepatitis C virus and chronic progressive kidney disease. Guidelines for detection, evaluation, treatment and prevention of infection transmission in hemodialysis units; procedure for infected patients-candidates for kidney transplantation and procedure for patients suspected of HCV infection-related kidney disease Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 67(4): 361-366
Chitalia, N.; Raja, R.B.; Bhandara, T.; Agrawal, P.; Kaski, J.C.; Jha, V.; Banerjee, D. 2010: Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation Journal of Nephrology 23(1): 77-84
Wetzel, O.; Hormi, M.; Le Normand, L.; Karam, G.; Guenel, J.; Auvigne, J.; Buzelin, J.M. 1993: Autosomal dominant polycystic kidney disease: urologic complications and results of kidney transplantation: 217 patients Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 3(2): 252-262
Cornu, F. 1998: Gaucher's disease and enzyme replacement therapy Annales Pharmaceutiques Francaises 56(3): 102-107
Shen, G.K.; Alfrey, E.J.; Knoppel, C.L.; Dafoe, D.C.; Scandling, J.D. 1997: Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation Transplantation 64(6): 931-933
Zimran, A.; Elstein, D. 2014: Management of Gaucher disease: enzyme replacement therapy Pediatric Endocrinology Reviews: Per 12(Suppl 1): 82-87
Ishida, Y.; Kawada, T.; Sugino, N. 1983: Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 56: 160-167
Fujita, T.; Miyazaki, M. 1971: Anesthetic management in kidney transplantation. 3. Anesthetic technic, postoperative complications, medical ethics and medicolegal problems Masui. Japanese Journal of Anesthesiology 20(4): 349-356
Parco, S.; Bruno, G.; Durighello, M.; Giorgini, R.; Simeone, R.; Bembi, B. 1999: Hematologic response in type i Gaucher's disease after enzyme replacement therapy Haematologica 84(4): 376-377
Ley-Martos, M.; Salado-Reyes, Mía.J.; Espinosa-Rosso, Rúl.; Solera-García, Jús.; Jiménez-Jiménez, L. 2015: Variability in the clinical presentation of Pompe disease: development following enzyme replacement therapy Revista de Neurologia 61(9): 416-420
Rosenthal, D.I.; Doppelt, S.H.; Mankin, H.J.; Dambrosia, J.M.; Xavier, R.J.; McKusick, K.A.; Rosen, B.R.; Baker, J.; Niklason, L.T.; Hill, S.C. 1995: Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase Pediatrics 96(4 Pt 1): 629-637
Liu, L.; Zhang, H.; Fu, Q.; Chen, L.; Sun, C.; Xiong, Y.; Shi, B.; Wang, C. 2014: Current status of pediatric kidney transplantation in China: data analysis of Chinese Scientific Registry of Kidney Transplantation Chinese Medical Journal 127(3): 506-510
Lavín-Gómez, B.A.; Palomar-Fontanet, R.; Gago-Fraile, M.; Quintanar-Lartundo, J.é A.; Gómez-Palomo, E.ía.; González-Lamuño, D.; García-Unzueta, M.T.; Arias-Rodríguez, M.A.; Gómez-Gerique, J.A. 2011: Inflammation markers, chronic kidney disease, and renal replacement therapy Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 27: 33-37
Takita, K.; Mashio, H.; Goda, Y.; Kawahigashi, H.; Kemmotsu, O. 1995: The duration of action of vecuronium in five patients after kidney transplantation--comparison with that during kidney transplantation Masui. Japanese Journal of Anesthesiology 44(6): 849-852